Advertisement
UK markets close in 5 hours 44 minutes
  • FTSE 100

    8,111.88
    +33.02 (+0.41%)
     
  • FTSE 250

    19,833.39
    +231.41 (+1.18%)
     
  • AIM

    755.73
    +2.61 (+0.35%)
     
  • GBP/EUR

    1.1653
    -0.0003 (-0.03%)
     
  • GBP/USD

    1.2515
    +0.0004 (+0.03%)
     
  • Bitcoin GBP

    51,528.75
    +445.41 (+0.87%)
     
  • CMC Crypto 200

    1,392.27
    -4.27 (-0.31%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    83.89
    +0.32 (+0.38%)
     
  • GOLD FUTURES

    2,361.60
    +19.10 (+0.82%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,042.03
    +124.75 (+0.70%)
     
  • CAC 40

    8,029.92
    +13.27 (+0.17%)
     

Shire Plc – Value Analysis (LONDON:SHP) : September 13, 2017

Shire Plc – Value Analysis (LONDON:SHP) : September 13, 2017

Categories: Europe Value Analsysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Shire Plc a score of 47. Our analysis is based on comparing Shire Plc with the following peers – GlaxoSmithKline plc, Hikma Pharmaceuticals Plc, AstraZeneca PLC and Pfizer Inc. (GSK-GB, HIK-GB, AZN-GB and PFE-SE). Investment Outlook Shire Plc has a fundamental score of 47 and has a ... Read more (Read more...)